On the Chapter 2.1.7 "Balances for Analytical Purposes" of the European Pharmacopoeia (Ph.Eur.)
Last updated: February 2022
Overview
The new Chapter 2.1.7 "Balances for Analytical Purposes" of the European Pharmacopoeia (Ph.Eur.) has been published in July 2021 and became effective on January 1, 2022. The Ph.Eur. is the legally binding reference for all pharmaceutical companies that place pharmaceutical products on the market in the European member states.
Download our FAQ guide to learn how you can ensure compliance with the updated European Pharmacopoeia guidelines and how our Cubis® II laboratory balance can help.
- Document type: Guide
- Page count: 4
- Read time: 7 minutes
Key Takeaways
- The new Ph.Eur. Chapter 2.1.7 specifies mandatory requirements for analytical balances, including calibration, performance testing and minimum sample weights
- Cubis® II balances support compliance with both Ph.Eur. Chapter 2.1.7 and USP Chapter 41
- Regular performance checks are recommended, with external service providers supplementing in-house checks
- Understanding the differences between multi-range and multi-interval balances is critical to selecting appropriate test loads and ensuring accurate performance testing
This Resource is Designed for:
- Lab Managers
- Lab Technicians
- Scientists
- Lab Assistants
- Pharmacology
- Pharmaceutical Companies
- Compliance Experts
Applications Supported:
- European Pharmacopoeia (Ph.Eur.) Guidelines
- Analytical Weighing
- Pharma Regulations
- Balance Calibration
